Stock quote - Summary

Alliance Pharma
APH: 59.50 +0.50 ( +0.85 %) delayed: 17:30PM
Bid price 59.50 High price 60.00
Ask price 60.00 Low price 58.36
Open price 60.00 Spread 0.83%
Prev close 59.50 Volume 185,042

Alliance Pharma - Share price charts

You need to install or upgrade your Flash Player
Historic - 1 year
You need to install or upgrade your Flash Player

Advanced Alliance Pharma charts >

Alliance Pharma - Share price information
Name Alliance Pharma Epic APH
Activities Alliance Pharma is an emerging speciality pharmaceutical company. The company has a strong track record of acquiring the rights to established niche brands and owns, or shares, the rights to 30 branded pharmaceutical products and continues to explore opportunities to expand the range. Alliance Pharma's products are prescribed in the treatment of a wide range of conditions and include brands used in periodontitis (a serious gum disease), the prevention of heart disease, in Parkinson's disease, in nutrition, in nasal infections, in the treatment of dermatological conditions and in childbirth. Alliance Pharma's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers which service both hospital and retail pharmacies with their prescription requirements. Alliance Pharma is also developing novel products for sleep disorders and the induction of labour. ISIN GB0031030819
Latest Share Price (p) 59.50 Net Gearing (%) 41.86
Market Capitalisation (pm) 270.16 Gross Gearing (%) 44.11
Shares in issue (m) 473.96 Debt Ratio 33.72
P/E Ratio 14.81 Debt-to-Equity Ratio 0.65
Total dividends per share (p) 1.21 Assets / Equity Ratio 1.79
Dividend Yield (%) 2.19 Price to book value 1.51
Dividend Cover 3.08 ROCE (%) 8.22
Earning per share (p) 3.85 EPS Growth (%) -17.20
52-week high / low (p) 60.00 / 41.50 DPS Growth (%) 10.00
Alliance Pharma - Broker views
Date Broker Recommendation Price Old target price New target price Notes
14 Sep finnCap Buy 58.00 58.00 Reiterates
13 Sep Numis Buy 60.00 60.00 Reiterates
24 Aug finnCap Buy 58.00 58.00 Reiterates
31 Jul finnCap Buy 65.00 58.00 Reiterates
18 Jul Numis Buy 60.00 60.00 Reiterates

More Alliance Pharma broker views >

Alliance Pharma - Director deals
Date Director Type Volume / Price Trade value
14 Feb 2017 Peter Butterfield Sale Post-Exercise 61,846 @ 48.75p £30,149.93
14 Feb 2017 Peter Butterfield Exercise 90,222 @ 33.25p £29,998.82
23 Sep 2016 John Dawson Sell 3,000,000 @ 45.25p £1,357,500.00
05 May 2016 David Cook Buy 47,879 @ 46.52p £22,273.31
05 May 2016 David Cook Buy 54,492 @ 46.54p £25,360.58

More Alliance Pharma director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.

Capita Asset Services is a trading name of Capita IRG Trustees Limited which is authorised and regulated by the Financial Conduct Authority and which is also authorised to conduct cross-border business within the EEA under the provisions of the EU Markets in Financial Instruments Directive. Registered office: The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU. Registered in England and Wales No. 2729260.